The aim of Accelerate@Babraham is to support the development of science concepts, the creation of new companies and help to grow early stage biomedical ventures by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors. The concept complements the Babraham Research Campus’ ongoing support of the Cambridge life science cluster through the provision of access to the campus community and infrastructure without the need to be an established occupier on site.
The second Accelerate@Babraham Start-ups Competition - giving selected ventures access to a five-month programme of lab access, mentoring and workshops - is currently underway. To find out more about the inaugural 2018 competition and the companies that successfully took part in that programme please click here.
Applications for the 2020 competition will be invited soon. Please check back regularly if you are interested in applying.
Through Accelerate@Babraham you will have access to:
Accelerate@Babraham is supported by a number of strategic partners. Current partners are AstraZeneca, Eli Lilly, MedImmune, One Nucleus and RxCelerate. Our partners endorse and support the concept by providing hands-on support to Accelerate@Babraham occupiers through a programme of mentoring and entrepreneurial guidance, as well as being actively involved in the ongoing strategic development of Accelerate@Babraham.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557